Dominic R. Cundari

Insider Reports History

Entity
Individual
Location
Two Carlson Parkway, Suite 260, Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dominic R. Cundari:

Stock Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Commercial Officer Voting Common Shares, no par value per share 2.8K $7.84K $2.80 Jun 1, 2024 Direct
DiaMedica Therapeutics Inc. Chief Commercial Officer Stock Option (right to buy) 15K Jun 1, 2024 Direct

Insider Reports Filed by Dominic R. Cundari

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DMAC DiaMedica Therapeutics Inc. Jun 1, 2024 1 $0 4 Jun 3, 2024 Chief Commercial Officer
DMAC DiaMedica Therapeutics Inc. Jun 1, 2023 1 $0 4 Jun 2, 2023 Chief Commercial Officer
DMAC DiaMedica Therapeutics Inc. Feb 1, 2022 2 $0 4 Feb 2, 2022 Chief Commercial Officer
DMAC DiaMedica Therapeutics Inc. Feb 1, 2022 0 $0 3 Feb 2, 2022 Chief Commercial Officer